Sangamo Therapeutics
SGMO
#10572
Rank
A$45.5 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-82.61%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -A$0.17 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$34.55 Million. In 2025 the company made an earning of -A$0.17 Billion a decrease over its 2024 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.17 Billion2.53%
2025 -A$0.17 Billion9.71%
2024 -A$0.15 Billion-17.27%
2023 -A$0.18 Billion-40.88%
2022 -A$0.3 Billion9.79%
2021 -A$0.28 Billion41.52%
2020 -A$0.2 Billion23.17%
2019 -A$0.16 Billion36.33%
2018 -A$0.12 Billion36.89%
2017 -A$83.66 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$69.55 Million75.62%
2014 -A$39.61 Million0.13%
2013 -A$39.56 Million
2011 -A$53.17 Million43.66%
2010 -A$37.02 Million28.52%
2009 -A$28.8 Million-23.55%
2008 -A$37.67 Million2.45%
2007 -A$36.77 Million19.5%
2006 -A$30.77 Million50.78%
2005 -A$20.41 Million75%
2004 -A$11.67 Million-33.25%
2003 -A$17.47 Million-62.27%
2002 -A$46.31 Million102.82%
2001 -A$22.83 Million23.21%
2000 -A$18.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.78 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.40 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$0.66 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$0.64 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.76 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$9.97 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.81 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$64.81 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA